INNOVATION PHARMACEUTICALS INC. Deferred Offering Costs
INNOVATION PHARMACEUTICALS INC. had Deferred Offering Costs of $159.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Deferred Costs, Current
us-gaap:DeferredOfferingCosts · last filed 2019-09-30
- 2018-09-30: Deferred Offering Costs $159.00K.
- 2018-06-30: Deferred Offering Costs $159.00K.
- 2018-03-31: Deferred Offering Costs $173.00K.
- 2017-12-31: Deferred Offering Costs $183.00K.
| Period end | Deferred Offering Costs |
|---|---|
| 2018-09-30 | $159.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $159.00K 10-K · filed 2019-09-30 |
| 2018-03-31 | $173.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $183.00K 10-Q · filed 2018-02-07 |
| 2017-09-30 | $212.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $227.00K 10-K · filed 2018-09-11 |
| 2017-03-31 | $269.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $310.00K 10-Q · filed 2017-02-09 |
| 2016-09-30 | $326.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $358.00K 10-K · filed 2017-09-11 |
| 2016-03-31 | $412.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $451.00K 10-Q · filed 2016-02-08 |
| 2015-09-30 | $469.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $494.00K 10-K · filed 2016-09-13 |
| 2015-03-31 | $499.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $94.00K 10-Q · filed 2015-02-09 |
| 2014-09-30 | $179.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $295.00K 10-K · filed 2015-09-11 |
| 2014-03-31 | $342.77K 10-Q/A · filed 2014-05-16 |
| 2013-12-31 | $372.63K 10-Q · filed 2014-02-10 |
| 2013-03-31 | $251.51K 10-Q · filed 2013-05-20 |
| 2012-12-31 | $297.00K 10-Q · filed 2013-02-13 |